Nutritional status in oncological patients may differ according to several modifiable and non-
modifiable factors. Knowledge of the epidemiology of malnutrition/cachexia/sarcopenia may …

Cachexia is a devastating, multifactorial and often irreversible systemic syndrome
characterized by substantial weight loss (mainly of skeletal muscle and adipose tissue) that …

Cancer cachexia (CC) is a multifactorial syndrome in patients with advanced cancer
characterized by weight loss via skeletal-muscle and adipose-tissue atrophy, catabolic …

Cancer-associated fibroblasts (CAFs) are essential for tumor microenvironment remodeling
and correlate with tumor progression. However, interactions between CAFs and tumor cells …

Tumor cells need to cope with the host environment for survival and keep growing in hard
conditions. This suggests that tumors must acquire characteristics more potent than what is …

Cachexia, the wasting syndrome commonly observed in advanced cancer patients,
accounts for up to one-third of cancer-related mortalities. We have established a Drosophila …

Cancer cachexia is a systemic metabolic syndrome characterized by involuntary weight loss,
and muscle and adipose tissue wasting. Mechanisms underlying cachexia remain poorly …

Cachexia, a wasting syndrome that is often associated with cancer, is one of the primary
causes of death in cancer patients. Cancer cachexia occurs largely due to systemic …

Cachexia, a multifactorial wasting syndrome, is highly prevalent among advanced-stage
cancer patients. Unlike weight loss in healthy humans, the progressive loss of body weight …

Excessive muscle loss is commonly observed in cancer patients and its association with
poor prognosis has been well-established. Cancer-associated sarcopenia differs from age …